Stocks · News reference
BioRestorative Therapies, Inc. (NASDAQ:BRTX) ("BioRestorative" or the "Company"), a late-stage clinical regenerative medicine company, today announced that the Company’s Board of Directors approved a
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Filed: 2026-09-11 AccNo: 0001213900-26-099018 Size: 193 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits
Filed: 2026-09-10 AccNo: 0001213900-26-098820 Size: 215 KB Item 4.01: Changes in Registrant's Certifying Accountant Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Snowflake shares surged 24% after Q2 revenue and earnings beat estimates; other premarket gainers and losers made notable moves.